Life Sciences, Clinical & Regulatory Operations
Published July 2026 · Last updated July 2026
Program economics in life sciences are decided over years and reported in fragments.
Who this is for
Clinical, regulatory, and commercial operations teams in life sciences and health technology organizations.
The problem
Program cost and cycle time are tracked in project systems that were built to manage tasks, not to compare programs. Portfolio prioritization decisions therefore rest on judgment supported by incomplete comparison.
What we build
Program-, site-, and portfolio-level cost and cycle time; wage and cost-benchmark signals joined to program spend; peer comparison where benchmarks exist; plain-language questions over live data.
Measures we surface
- Program cost and burn against plan
- cycle time and milestone attainment
- site and study performance
- portfolio prioritization and comparison
- vendor and CRO performance
- regulatory submission timelines
How it’s delivered
Pathfinder Elements brings the platform to market three ways. We work directly with organizations where a sector’s operating model calls for close design work. We license to resellers and distribution partners who already serve a market and deliver the platform, configured, to their own customers. And we co-develop sector capability with software and services partners, combining our analytics core with their domain systems and market access. Prospective partners are welcome to get in touch.